Ledger.Open graph →
SEC Form D · Amendment · filed November 20, 2015

Amylyx Pharmaceuticals, Inc

Offering
$1.6M
Sold
$1.4M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (15)

Justin Klee · Cambridge, MADirectorJoshua Cohen · Cambridge, MAExec · DirectorPeter B. Finn · Boston, MAExecStephen D. Chubb · Cambridge, MADirectorGeorge M. Milne, Ph.D · Cambridge, MADirectorJames F. Kellogg Iii · Boston, MADirectorEric M. Siegal · CHICAGO, ILExecVikram F. Punwani · Boston, MADirectorChristopher F. Linneman · Boston, MAExec · DirectorJonathan J. Desimone · Boston, MADirectorDaniel M. Rosenbloom · CHICAGO, ILExecMikhail Plam · Louisville, CODirectorDavid C. Barker · Louisville, COExec · DirectorVincent P. Mihalik · Louisville, CODirectorNiles C. Utlaut · Louisville, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗